Can You Live With Half a Heart? The Science Explained

People born with only one functioning heart ventricle can survive into adulthood, though the path involves multiple open-heart surgeries, lifelong medical management, and a circulatory system that works in fundamentally different ways than a normal heart. Before the 1980s, conditions like hypoplastic left heart syndrome carried roughly 95 percent mortality within the first month of life. Today, a series of staged surgical procedures reroutes blood flow so that a single ventricle does the work normally split between two, and growing numbers of these patients are reaching their thirties, forties, and beyond.

What “Half a Heart” Actually Means

The phrase “half a heart” is informal, but it maps onto a real category of birth defects that cardiologists call single-ventricle physiology. The most severe and well-known example is hypoplastic left heart syndrome, or HLHS, in which the left side of the heart is so underdeveloped that it cannot pump blood to the body. The left ventricle, the aortic valve, the mitral valve, and the ascending aorta may all be abnormally small, narrowed, or completely sealed off.¹ Other conditions can also leave a baby with only one usable ventricle, including tricuspid atresia, double-inlet left ventricle, and unbalanced atrioventricular canal defects. The unifying feature is that the heart’s ventricular mass cannot be divided into two separate pumps, one for the lungs and one for the body, the way a normal heart works.²

In a healthy heart, deoxygenated blood flows to the lungs through the right ventricle, picks up oxygen, returns to the left side of the heart, and gets pumped out to the body by the left ventricle. These two circuits run in series, each with its own pump. When one ventricle is missing or useless, the entire circulatory workload falls on the remaining chamber. The surgical goal is not to fix the missing half but to reorganize the plumbing so that one ventricle can sustain life.

The Three-Stage Surgical Pathway

Survival depends on a sequence of three open-heart operations performed over the first few years of life. Each builds on the last, gradually transitioning the baby from a chaotic mixing of oxygenated and deoxygenated blood to a more efficient arrangement where the single ventricle is dedicated to pumping blood to the body.

The first surgery, the Norwood procedure, typically happens within the first week of life. It reconstructs the aorta, connects it to the single working ventricle, and creates an artificial pathway for blood to reach the lungs. A small tube called a shunt provides pulmonary blood flow. This stage carries the highest risk. Historically, a modified Blalock-Taussig shunt has been used for this purpose, though a right ventricle-to-pulmonary artery shunt is an alternative approach. The right ventricle-to-pulmonary artery shunt may improve blood flow to the coronary arteries, but it requires cutting into the ventricle itself.³ Techniques for reconstructing the aortic arch have also been refined over the years to avoid re-narrowing of the aorta and to protect coronary blood flow.⁴

The second surgery, typically performed around four to six months of age, is the Glenn procedure. It disconnects the shunt from the first operation and instead connects the superior vena cava directly to the pulmonary artery. Blood returning from the upper body now flows passively into the lungs without being pumped. This reduces the single ventricle’s workload considerably.⁵ Studies comparing surgical templates at this stage have found that the Glenn connection, with its direct end-to-side attachment, tends to be more efficient than alternative configurations, producing substantially lower energy losses as blood flows through the junction.⁶

The third and final surgery, the Fontan procedure, is usually completed between ages two and four. It reroutes the remaining deoxygenated blood, returning from the lower body, directly to the lungs as well. After this operation, all venous blood reaches the lungs passively, driven only by the pressure in the veins. The single ventricle is now fully dedicated to pumping oxygenated blood to the body. First performed in 1971, the Fontan procedure has undergone enormous technical refinement over five decades.⁷

How Fontan Circulation Differs from Normal

Once the Fontan is complete, the patient has a functional circulatory system, but one that operates under very different rules. In a normal heart, the right ventricle actively pumps blood through the lungs. In a Fontan circulation, there is no pump on the lung side at all. Blood gets to the lungs solely because the pressure in the veins is higher than the pressure in the pulmonary arteries. This means that central venous pressure, normally a background measurement, becomes the driving force for pulmonary blood flow.⁸

This passive flow arrangement works, but it comes at a cost. Venous pressure must stay chronically elevated to keep blood moving through the lungs. That elevated pressure backs up into every organ that drains into the venous system, particularly the liver, the gut, and the lymphatic system. Research has found a strong link between rising venous pressure and worsening resistance in the lung blood vessels among Fontan patients, a relationship that does not exist in people with normal hearts. Higher pulmonary vascular resistance also independently predicts a greater risk of Fontan failure and death.⁸

The Liver Problem

One of the most significant long-term consequences of Fontan circulation is liver disease. The chronically high venous pressure pushes blood backward into the liver, causing congestion. Essentially all Fontan patients develop some degree of liver scarring, and surveillance biopsies have shown that virtually everyone develops clinically silent fibrosis by adolescence.⁹ This condition, called Fontan-associated liver disease, is driven by the combination of elevated venous pressure and reduced cardiac output that are inherent to the Fontan circulation.¹⁰

For many patients, the fibrosis remains stable for years. But as the duration of Fontan circulation increases, the risk of progression to cirrhosis and even liver cancer grows. Some patients develop complications of portal hypertension, and there are increasing reports of young adults requiring combined heart-liver transplantation.¹¹ Monitoring the liver has become a standard part of Fontan follow-up care, though there is no consensus yet on how best to screen for or prevent progression.

Other Complications of Living on One Ventricle

The lymphatic system takes a beating in Fontan circulation too. Elevated venous pressure and increased lymphatic production can overwhelm the body’s ability to drain lymph fluid normally. When lymphatic fluid leaks into the wrong places, two particularly serious conditions can result: protein-losing enteropathy, where protein is lost through the gut wall, and plastic bronchitis, where thick casts of lymphatic material form in the airways. Five-year survival for patients who develop these complications has been reported to range from roughly 46 to 88 percent, making them among the most feared consequences of Fontan physiology.¹² Both conditions share a common mechanism rooted in lymphatic disruption, and newer therapies targeting the lymphatic system are beginning to emerge.¹³

Exercise and Physical Limits

Most people living with a Fontan circulation experience some degree of exercise intolerance, and reduced fitness is linked to a worse long-term outlook.¹⁴ The reason is straightforward: during exercise, a normal heart can dramatically increase the amount of blood pumped through the lungs by revving up the right ventricle. A Fontan patient has no right ventricle to ramp up. Blood flow to the lungs depends on passive venous return, which has a hard ceiling. Research using advanced imaging has shown that energy losses at the surgical connection points inside the chest rise during exercise, and higher energy losses correlate with lower oxygen consumption and reduced work capacity.¹⁵

That said, exercise training does help. A systematic review of 16 studies found that more than half showed significant improvement in peak oxygen uptake after a training program, with an average increase of about 6 percent. The biggest gains reached around 15 percent in one study.¹⁶ These are modest gains compared with what a healthy person might achieve through training, but for a Fontan patient, even a small improvement can translate to meaningful gains in daily function.

Quality of Life and Mental Health

The question most families want answered is not just whether their child will survive, but what kind of life they will have. The research here paints a mixed but cautiously encouraging picture. Adult Fontan survivors tend to score lower than healthy peers on physical functioning, general health perception, and bodily pain measures. But on social functioning, mental health, and overall mental well-being, scores are often comparable to the general population. One study found that this favorable period of life satisfaction lasted an average of 18 years after the Fontan operation.¹⁷ A separate study from an Asian population found no significant differences in functional health status or quality of life between Fontan patients and age-matched peers without congenital heart disease, after adjusting for age, sex, and ethnicity.¹⁸

The Australian and New Zealand Fontan Registry, drawing from a larger cohort, found that adults with Fontan circulation reported lower physical and social functioning compared with population norms, but that most participants still rated their overall quality of life at 7 out of 10 or higher.¹⁹ Mental health, however, deserves attention. Fontan patients and adolescents show higher rates of depression and emotional vulnerability compared to healthy peers. In one national cohort, adolescent Fontan patients had lower scores on emotional symptoms scales, and females appeared to be at higher risk for impaired mental health.²⁰ Another study found that Fontan patients were more depressed than healthy counterparts, and that functional status, depression, and social support together accounted for more than half the variation in quality of life.²¹

Brain Development and Learning

Children with single-ventricle hearts face neurodevelopmental challenges that are distinct from the heart itself. Multiple open-heart surgeries in infancy, periods of low oxygen, and time on cardiopulmonary bypass all carry risks for the developing brain. Studies have consistently found that children with single-ventricle lesions score lower than normal across developmental domains by age three. Complications during treatment, abnormal growth, and problems with feeding, vision, or hearing were independently associated with worse outcomes, though collectively these factors explained less than a third of the variation in scores.²²

In the subgroup of patients who underwent the Norwood procedure specifically, head circumference at birth and complications before the first surgery were independent predictors of how children scored on neurodevelopmental tests. Longer hospital stays after the Norwood also predicted worse outcomes.²³ The takeaway for families is that early intervention services, educational support, and regular developmental screening are as much a part of single-ventricle care as the cardiology appointments.

Pregnancy With a Fontan Circulation

Women who have undergone the Fontan procedure can become pregnant, but it carries substantial risk. A systematic review covering 255 pregnancies in 133 women found that only about 45 percent resulted in live births. Miscarriages accounted for the largest share of pregnancy losses, and among the babies who were born alive, roughly 59 percent were premature and about 20 percent were small for gestational age.²⁴ Postpartum hemorrhage was the most common obstetric complication, affecting about 14 percent of patients. Arrhythmias and heart failure occurred but were generally manageable, and no maternal deaths were reported in the reviewed studies.

A smaller study of 15 completed pregnancies found obstetrical complications in 40 percent, including placental abruption, premature membrane rupture, and bleeding before delivery. Despite this, there were no maternal deaths or episodes of heart failure decompensation during the pregnancies.²⁵ Factors associated with better pregnancy outcomes include younger age, normal body weight, minimal functional limitation, no existing Fontan complications, and good single-ventricle function.²⁶ Pregnancy in this population requires intensive planning and monitoring by a team that understands both the cardiac and obstetric risks.

When the Fontan Fails

The Fontan circulation is palliative, not curative. Over time, the single ventricle may weaken, venous pressures may climb further, and the cascade of complications may become unmanageable. When that happens, heart transplantation remains the only definitive treatment. Single-ventricle patients are the most rapidly growing group presenting for cardiac transplantation, and they represent one of the most complex cohorts for transplant teams. Multiple prior surgeries, unusual anatomy, immune sensitization from earlier blood products, and multi-organ involvement all raise the operative risk.²⁷

Outcomes after transplant vary depending on the stage at which the patient’s circulation failed. One long-term study found that patients who received a transplant after the Glenn stage had excellent long-term survival, while those transplanted after a failing Fontan had significantly worse outcomes, with the failing Fontan itself identified as a predictor of higher mortality after transplant.²⁸ This finding underscores a difficult tension: waiting longer may allow a patient to benefit from years of Fontan circulation, but delaying transplant until the Fontan is truly failing may worsen transplant outcomes.

For patients too sick to wait for a donor heart, mechanical support devices such as ventricular assist devices can serve as a bridge. But these pumps were designed for two-ventricle hearts, and as of 2020 no device had been engineered specifically for Fontan anatomy. Installing a standard assist device often requires partially deconstructing the Fontan plumbing, and patients with congenital heart disease who receive these devices have higher mortality than non-congenital patients, though they still show improvement in functional capacity and quality of life.²⁹ In the most severe cases, a total artificial heart has been implanted in Fontan patients as a bridge to transplant, though the procedure requires significant modification from its standard technique.³⁰

Emerging Research and Engineering

Two frontiers may reshape single-ventricle care in the coming decades. The first is stem cell therapy. Animal studies have shown that stem cell treatments can be safe and effective in models of HLHS, and several clinical trials have been designed to test mesenchymal stem cells in patients with single-ventricle physiology.³¹ No large-scale clinical trials in congenital heart disease have been completed yet, but early-phase investigations suggest the approach has potential, particularly given the striking advances made with stem cell therapy for adult heart failure over the past decade.³²

The second frontier is biomedical engineering. Computational fluid dynamics, the same kind of simulation technology used to design airplane wings, is now being applied to optimize the geometry of Fontan conduits. Researchers can model blood flow through a virtual version of a patient’s specific anatomy and test different conduit sizes and shapes before the surgeon ever enters the operating room. Upsizing a conduit in simulations has been shown to reduce energy losses by anywhere from 16 to 63 percent, with the benefit depending heavily on the individual patient’s anatomy.³³ Custom-designed conduits generated by computer-aided design and optimized through these simulations could eventually replace the standard off-the-shelf grafts used today, tailoring the surgery to each patient’s unique chest.³⁴ In a circulation where every fraction of wasted energy matters, even modest improvements in conduit design could translate into years of better function.